President Trump unveils TrumpRx, a website to purchase low cost prescription drugs — 2/5/2026

Key Concepts

• TrumpRx.gov: A new website launched to provide discounted prescription drugs to American consumers.
• Most Favored Nation (MFN) Agreements: Agreements negotiated by the Trump administration to ensure the US pays the lowest price for drugs, equal to that paid by any other country.
• GLP-1s: A class of drugs used for weight loss (e.g., Ozempic, Wegovy).
• Tariffs: Taxes imposed on imported goods, used as leverage to negotiate lower drug prices.
• National Design Studio: A team responsible for the design and user experience of TrumpRx.gov.
• In Vitro Fertilization (IVF): Assisted reproductive technology, with medication costs significantly reduced through the initiative.

Lowering Prescription Drug Costs: A Launch Event Summary

Introduction & Historical Context

Former President Donald Trump announced the launch of TrumpRx.gov, a website designed to offer significant discounts on commonly used prescription drugs to all American consumers. He framed this as a historic achievement, contrasting it with decades of failed promises from politicians of both parties to address high drug prices. He asserted that the US has historically subsidized drug costs for the rest of the world, paying significantly higher prices than other nations. Specifically, the US, representing 4% of the world’s population, accounts for 75% of pharmaceutical revenue.

The Most Favored Nation (MFN) Approach

The core of the initiative is based on “Most Favored Nation” agreements. These agreements, negotiated by the Trump administration, mandate that the US will pay no more for a drug than the lowest price paid by any other country. To enforce this, the administration utilized tariffs, threatening to impose them on nations that did not agree to raise their drug prices, thereby lowering prices for the US. Trump stated that drug costs in other nations will increase, “by double and even triple,” while US prices will decrease by “300, 400, 500, even 600%” in some cases.

Specific Drug Price Reductions & Examples

Several specific examples of price reductions were highlighted:

• Ozempic (Novo Nordesk): Reduced from over $1,000 to $199 (a 578% difference).
• Wegovy (Novo Nordesk): Reduced from over $1,300 to $199.
• Insulin (Eli Lilly): Reduced from $200 to $25.
• Asthma Inhaler (AstraZeneca): Reduced from $458 to $51 (nearly 800% difference).
• Gonol F (EMD Serono - IVF drug): Price reduction to the lowest in the developed world, previously the highest paid by the US.

These reductions are available through the TrumpRx.gov website, where consumers can obtain coupons to redeem at pharmacies. The website also identifies pharmacies where specialty drugs like Gonol F can be ordered for home delivery.

Expanding Drug Coverage & Manufacturing Return

Currently, the website offers discounts on over 40 medications, with plans to expand the list continuously. Sixteen of the seventeen largest pharmaceutical companies have signed agreements committing to MFN pricing for all new drugs they bring to market in the US, with the remaining company expected to follow suit.

Beyond price reductions, the initiative aims to incentivize domestic drug manufacturing. Trump stated that pharmaceutical companies are investing “hundreds of billions of dollars” to bring manufacturing back to the US, citing Eli Lilly’s construction of six new plants as an example. This is driven by the threat of tariffs on goods manufactured abroad. He claimed that over $18 trillion is flowing into the US due to companies relocating manufacturing to avoid tariffs.

Website Functionality & User Experience

Joe Gibbia, Chief Design Officer of the United States, demonstrated the TrumpRx.gov website. Users can search for drugs by name, view discounted prices (indicated as a percentage off the original price), obtain coupons, and locate pharmacies offering the medication. The site also suggests commonly prescribed drugs alongside the searched medication, all covered by the same coupon.

Personal Testimony & Impact

Katherine, a military spouse undergoing IVF treatment, shared her personal story. She emphasized the financial burden of fertility medications and expressed gratitude for the potential to access affordable treatment through the initiative, stating it “can mean the difference between being able to continue treatment or having no choice but to stop.” Dr. Oz noted that one in three families struggle to afford medications.

Concluding Remarks & Future Outlook

Trump concluded by reiterating the initiative’s focus on “America First” and the potential for significant savings for American consumers. He projected that Americans could lose approximately 100 million pounds due to the reduced cost of weight loss medications. He credited the team involved, including Dr. Oz, Joe Gibbia, and Bobby Kennedy Jr., for their contributions. He emphasized that the launch is just the beginning, with more drugs being added to the website regularly.

Data & Statistics Mentioned:

• US Population: 4% of the world’s population.
• US Prescription Drug Consumption: 13% of all prescription drugs.
• Pharmaceutical Revenue from US: 75% of global revenue.
• Ozempic Price Reduction: Over $1,000 to $199 (578% difference).
• Wegovy Price Reduction: Over $1,300 to $199.
• Insulin Price Reduction: $200 to $25.
• Asthma Inhaler Price Reduction: $458 to $51 (nearly 800% difference).
• Projected Weight Loss: 100 million pounds annually.

Logical Connections:

The presentation followed a logical flow: establishing the problem of high drug prices, presenting the MFN solution, detailing specific price reductions, explaining the website’s functionality, and highlighting the broader economic benefits of reshoring manufacturing. The personal testimony served to underscore the real-world impact of the initiative.

Synthesis/Conclusion:

The launch of TrumpRx.gov represents a significant attempt to address the long-standing issue of high prescription drug prices in the US. By leveraging MFN agreements and the threat of tariffs, the administration aimed to secure lower prices for American consumers, bringing them in line with those paid in other countries. The initiative’s success hinges on the continued participation of pharmaceutical companies and the ongoing expansion of drug coverage on the TrumpRx.gov website. The focus on domestic manufacturing further aims to bolster the US economy and enhance national security.